ACIU logo

ACIUAC Immune SA

$2.25
$0.15
(6.25%)
Today
Closed $2.25
$0.07
(3.11%)
After Hours
Updated: 07:49 PM EDT
EarningsAug 4
Mkt Cap$244.26M
Vol328,077.00
News
all
press releases
AC Immune (ACIU) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
AC Immune (ACIU) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Zacks
News Placeholder
More News
News Placeholder
Agilent Technologies Q2 Earnings Beat Estimates, Revenues Up Y/Y
A beats Q2 earnings and revenue estimates as recurring revenue hits 66% of sales, but shares lost despite raised fiscal 2026 guidance.
Zacks
News Placeholder
AC Immune (ACIU) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
AC Immune (ACIU) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Zacks
News Placeholder
AC Immune CEO Andrea Pfeifer To Retire, Board Chair Martin Z gel To Be Interim CEO
(RTTNews) - Tuesday, AC Immune SA (ACIU) announced that Chief Executive Officer Andrea Pfeifer has decided to retire from her role at the upcoming Annual General Meeting to spend more time with her...
Nasdaq News: Markets
News Placeholder
HC Wainwright Has Positive View of AC Immune FY2027 Earnings
AC Immune (NASDAQ:ACIU - Free Report) - Stock analysts at HC Wainwright raised their FY2027 earnings estimates for shares of AC Immune in a report issued on Monday, May 4th. HC Wainwright analyst A...
MarketBeat
News Placeholder
BTIG Research Reaffirms "Buy" Rating for AC Immune (NASDAQ:ACIU)
BTIG Research restated a "buy" rating and set a $8.00 price objective on shares of AC Immune in a research report on Monday...
MarketBeat
News Placeholder
AC Immune (NASDAQ:ACIU) Announces Earnings Results
AC Immune (NASDAQ:ACIU - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of...
MarketBeat
News Placeholder
AC Immune (ACIU) Reports Q1 Loss, Tops Revenue Estimates
AC Immune (ACIU) delivered earnings and revenue surprises of +5.00% and +42.82%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
AC Immune (ACIU) to Release Quarterly Earnings on Wednesday
AC Immune (NASDAQ:ACIU) will be releasing its Q1 2026 earnings before the market opens on Wednesday, April 29. (View Earnings Report at...
MarketBeat
News Placeholder
ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know
AC Immune stock gains after expansion of its agreement with LLY, adding next-generation Tau Morphomer candidates and boosting long-term Alzheimer's strategy.
Zacks
<
1
2
...
>